Introduction
Influenza is considered a major cause of morbidity and mortality worldwide. The World Health Organization (WHO) estimates that influenza epidemics result in three to five million cases of severe illness, and about 250,000 to 500,000 deaths worldwide annually [1] .
Influenza-related hospitalizations and fatal cases mainly occur among high-risk groups: in the very young, elderly, and chronically ill. In industrialized countries most influenza-associated deaths occur among people over 65 years of age [1] . Annual vaccination constitutes the most effective method to reduce the burden of influenza disease. Among healthy adults (aged years), parenteral influenza vaccines are 80% efficacious against influenza when there is a good match between the vaccine components and the circulating virus strains [2] . However, the effectiveness of the vaccine depends also on the age and immunocompetence of the individual vaccinee [3] . Even though technically feasible, the control of influenza through vaccination poses a great challenge to public health authorities. Current seasonal influenza vaccines, which usually contain three virus subtypes, have to be adjusted annually in order to protect against the virus strains expected to circulate in the upcoming season. Consequently, people at risk as well as everyone who would like to minimize his or her risk of getting infected with influenza have to be reminded of their seasonal influenza shot every year. Furthermore, they need be motivated to actually receive it, and access to vaccination needs to be ensured.
In Germany, an estimated one to five million additional physician consultations are attributable to influenza virus infections during an average influenza season [4] . In seasons with high influenza-activity (e.g. season 1995/1996) it is estimated that there are up to 30,000 excess deaths attributable to influenza [5, 6] . The German Standing Committee on Vaccination (STIKO) currently recommends seasonal influenza vaccination for the following target groups: (1) persons aged ≥60 years, (2) persons with an underlying chronic disease, (3) persons living in nursing or old people's homes, (4) persons with an increased professional 4/24 risk (e.g. persons who work in the medical sector), and (5) pregnant women [7] . The vaccination of people belonging to these target groups is free of charge in Germany. Vaccines are usually administered by private physicians, and reimbursement is provided to these physicians by the statutory health insurance fund [8] . In addition, a small but not quantifiable proportion of influenza vaccinations is administered by occupational health physicians.
Since 2006, nation-wide seasonal influenza vaccination campaigns are conducted in Germany each season [9] . Unlike other European countries such as Norway, Belgium, and the Netherlands, Germany has no central immunization register [10] . With the implementation of the 'German Health Update' Survey (GEDA) in 2008, a monitoring tool is now available in Germany for the detailed assessment of vaccination coverage in all age-groups above 18 years. GEDA is a large, population-representative telephone-survey, which is planned to be 
Methods

Study population
Germany has a population of approximately 82 million people, of which 68.3 million (83.3%) are 18 years of age or older (Table 1) [11] . A total 65.5 million live in the 10 Western Federal States (WFS) and 16.5 million live in the 6 Eastern Federal States (EFS) [12] . Our study population included persons ≥18 years of age living in private households in Germany and who were able to be contacted by landline telephone. According to the federal network agency there were 38.9 million landline telephones registered in Germany in 2009 [13] .
Criteria for exclusion were age ≤17 years or insufficient knowledge of German language.
Survey design
Data on influenza vaccination coverage in Germany was collected within the framework of the national telephone health survey GEDA 2009. GEDA is a cross-sectional survey which is part of Germany's nationwide health monitoring. The survey was conducted for the first time between July 2008 and June 2009 and is planned to be carried out on a regular basis in the future. Data acquisition was conducted via computer-assisted telephone interview (CATI) by trained interviewers. The Gabler/Häder sampling design and the last birthday method were used to ensure representativeness [14;15] . Moreover, weighting factors were used in order to make the study population comparable to the general population in Germany. The weighting factors were constructed by taking age, gender, educational status, geographic region, community size and household size into consideration. If not indicated otherwise, all data presented in this paper are weighted data. Response rates were calculated using Response Rate 3 as defined by the American Association for Public Opinion Research (AAPOR) [16] . Response Rate 3 is defined as the number of complete interviews divided by the number of interviews plus the number of non-interviews plus cases of unknown eligibility.
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Response Rate 3 estimates what proportion of cases of unknown eligibility is actually eligible. The cooperation rate at respondent level is defined as the proportion of all cases interviewed of all respondents ever contacted. This rate is calculated using only contacts with and refusals from known respondents [16] .
The study protocol of the GEDA survey was approved by Germany's federal and regional data-protection commissioners. All data were collected and analyzed in an anonymous manner. Persons were classified into target groups if they reported (1) to be ≥60 years of age, [17] . The educational status 'low' comprised ISCED 97 levels 1 and 2, 'medium' comprised levels 3 and 4, and 'high' comprised levels 5 and 6. To allow comparability among the interviewed persons, household income was adjusted for household size and age of household members by calculating the net equivalent income according to the Organisation for Economic Co-operation and Development (OECD)-modified equivalence scale method [18] . A net equivalent income <70% of the median net equivalent income in the study sample was classified as 'low', those between 70% and 120% of the median as 'medium', and those >120% of the median as 'high'.
Definitions
Statistical analysis
Statistical analysis was performed using PASW version 18.0 for Windows (SPSS Inc., Chicago, USA) and EpiInfo version 3.5.1 for Windows (Centres for Disease Control and Prevention, Atlanta, USA). Univariate analyses were performed by using the complete or a stratified data set. Bivariate associations of categorical variables were assessed by using
Pearson's Chi-square test. A two-sided p-value <0.05 was considered to indicate a statistically significant difference. Odds ratios (OR) and 95% confidence intervals (CI) were calculated as appropriate. Multivariate analysis was performed by using logistic regression models. Age, sex, and all variables identified in univariate analysis to be potentially associated with influenza vaccination (i.e. p-value <0.2) were included in the first step of the multivariate analyses. Thereafter we removed non-significant independent factors (i.e. p-value ≥0.05) from regression models in a stepwise backward fashion to produce final models. years in the second sub-sample. An overview of the adult population in Germany and the two study sub-samples is given in Table 1 and does not reveal any statistically significant difference in the distribution of demographic characteristics. Vaccination coverage by target group, sex, and residency is presented in Table 2 .
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Results
Sample characteristics
Influenza vaccination coverage in the general population
Among persons ≥60 years, 53.3% also had an underlying chronic disease. 
Analysis of factors potentially associated with vaccine uptake in target groups
As differences in vaccination coverage were marginal between seasons, univariate and multivariate analysis of factors potentially influencing influenza vaccine uptake in target groups was performed by using the complete data set (n=21,262). Results of the analysis are presented in Table 4 . Living in the EFS, older age, and medium household income level were independently associated with higher vaccine uptake in persons with an underlying chronic disease and in persons ≥60 years of age (Table 4 ). In the latter group, belonging to more than one target group was identified as an additional factor associated with vaccine uptake and increased the odds of being vaccinated by 58%. In HCWs only residency remained a significant factor in multivariate analysis. Multivariate analysis revealed no significant association between educational status and influenza vaccination coverage in any of the target groups.
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Discussion
The World Health Assembly (WHA) has embarked on the goal of attaining influenza vaccination coverage of at least 75% in the elderly population by 2010 [19] . Here we present vaccination coverage data from two influenza seasons in Germany, which were collected in the general adult population as well as in high-risk and other target groups by interviewing a large population-representative sample. Vaccination coverage in the target groups remained low, especially among persons with underlying chronic conditions (~42%) and HCWs reporting on avian influenza in the media during that year [21] .
Multivariate analysis of potential factors as well as analysis of vaccination coverage stratified by type of chronic underlying condition revealed that STIKO-recommendations are not effectively implemented in the younger age groups. It can be assumed that these groups have less frequent contact to their family doctor who could remind them about the vaccination. Further research is needed to explore the reasons for low vaccine uptake in these groups and to identify better access paths to vaccination.
Previous studies have consistently found that acceptance of annual influenza vaccination is considerably higher in the EFS [22, 23] . Significantly higher vaccination 12/24 coverage was also found in our study participants living in the EFS, both in the general population and in the target groups examined. The reasons for higher vaccination coverage in the EFS are complex and not adequately investigated yet. One reason may be that -although reunification of East and West Germany took place over twenty years ago -mandatory vaccination practices in the former German Democratic Republic still influence today's general attitude and behaviour towards vaccinations in the EFS [22, 24] . Moreover, differences in vaccination policies on federal state level can be observed between the eastern and western states. For example, the eastern federal state of Saxony-Anhalt is currently the only state in Germany that established a state level immunization registry to assess complete vaccination data of the total federal childhood population below 8 years of age [10] .
Similar to previous studies surveying influenza vaccination coverage in Germany [21, 23, [25] [26] [27] [28] , the lowest coverage in our study was found in HCWs. Coverage among HCWs was even significantly lower than in the general adult population. These findings are of special concern. First, due to their profession HCWs are more likely to be exposed to influenza-patients. Second, if infected they can serve as a source of infection to their unvaccinated patients, who might have underlying chronic diseases that put them at higher risk for severe influenza disease. And most importantly, HCWs can be regarded as important multipliers for the implementation of vaccinations in high risk groups. HCWs do not only have the expertise in vaccine-related topics, but due to their profession they also have access to high risk groups and can often influence the attitude of their patients towards vaccinations.
New approaches to enhance vaccine uptake among HCWs in Germany are currently discussed [29] . Low vaccination coverage among HCWs has been observed not only in Germany but also in several other European and non-European countries [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] . assessed by Blank et al. was similar to that found in our study [20] , vaccination coverage in the target groups diverged significantly from our findings. Vaccination coverage in persons ≥65 years of age (48.7% vs. 61.1%) and in persons with underlying chronic conditions (26.5% vs. 43.8%) was considerably lower than in our study population. However, it should be noted that our study sample was with over 15,000 interviewed persons more than seven times larger than the study sample examined by Blank et al. [20] and can therefore possibly be regarded as more representative especially in smaller subgroups.
14/24
Our study has several limitations. Vaccination status and chronic underlying disease status were self-reported by the survey participants and, as the survey was anonymous, could not be verified by any medical record documentation. However, self-report of influenza vaccination status has been previously found to have an adequate degree of reliability [41, 42] , and we only asked for influenza vaccinations in the previous one or two seasons. Only telephone landlines were used in the GEDA-Survey. Consequently, people using exclusively a mobile phone were not included in this study. Mobile phone numbers were not used because they cannot be randomly selected easily and do not allow any regional mapping in Germany.
Due to the fact that many mobile phone users have an additional landline number, it is very likely that this group was at least partly represented in our study population. Furthermore the response rate (29.1%) in GEDA 2009 was relatively low. It should be emphasized that we used a very conservative approach to calculate the response rate [16] and that our response rate is comparable to other studies using a similar approach (e.g. CDC-Behavioral Risk Factor
Surveillance System [43] ). Considering the complex weighting procedures used in GEDA 2009 and the good cooperation rate (51.2%) it can be assumed that data quality is overall good in our study. A further limitation of the study was that persons who were not able to speak German or could not be interviewed via telephone (e.g. some persons in nursing or old people's homes) were excluded from the survey.
In conclusion, our results indicate that influenza vaccination coverage in the target groups in Germany is still unsatisfactorily low. Especially the low vaccination coverage in persons with chronic underlying diseases and in HCWs is of concern. Special effort must be undertaken to improve vaccine uptake in HCWs, since this group can be regarded as 
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